-
in neurodegenerative and neuromuscular disorders. The researcher will be based at the Institute of Biotechnology, University of Helsinki. The Institute provides state-of-the-art research
-
spectrometry-based proteomics to understand how proteins, their interactions, and their modifications drive disease and drug response, and we develop the methods to address these questions across basic, clinical
-
approaches to large-scale biomedical data. Research topics may include foundation models for longitudinal electronic health records and genomics, multimodal learning integrating health records with molecular
-
. Research topics may include foundation models for longitudinal electronic health records and genomics, multimodal learning integrating health records with molecular data, causal representation learning, in